Cronos Group CRON Business Segments
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Net revenue by Product | |||||
| Cannabis extracts | $37.7M+29.3% | $29.17M+2,735% | $1.03M-88.7% | $9.14M— | |
| Cannabis flower | $108.48M+23.4% | $87.91M+41.6% | $62.07M-2.4% | $63.59M+15.2% | |
| Net revenue by Geography | |||||
| Canada | $90.33M+9.6% | $82.44M+27.4% | $64.7M+15.1% | $56.23M+11.8% | |
| Israel | $41.8M+47.3% | $28.37M+34.2% | $21.13M-30.7% | $30.52M+128% | |
| Other countries | $14.46M+112% | $6.81M+385% | $1.41M— | $0-100% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Cronos Group break its business down?
- Cronos Group (CRON) reports net revenue by product across 2 parts — Cannabis extracts and Cannabis flower. Each is extracted from the segment footnotes and tracked over time.
- Where does Cronos Group's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Cronos Group's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
